|
Oct 9
|
Wall Street Analysts Think Kiniksa Pharmaceuticals (KNSA) Could Surge 42.34%: Read This Before Placing a Bet
|
|
Oct 9
|
Baker Bros. Advisors LP Increases Stake in Kiniksa Pharmaceuticals
|
|
Jul 26
|
Kiniksa Pharmaceuticals, Ltd. (KNSA) Is Up 0.09% in One Week: What You Should Know
|
|
Jul 26
|
Recent Price Trend in Kiniksa Pharmaceuticals (KNSA) is Your Friend, Here's Why
|
|
Jul 24
|
Kiniksa Pharmaceuticals International And Two More Firms Possibly Priced Below Market Value Estimates
|
|
Jul 23
|
Kiniksa Pharmaceuticals, Ltd. (KNSA) Reports Q2 Loss, Tops Revenue Estimates
|
|
Jul 23
|
Kiniksa Pharmaceuticals Reports Second Quarter 2024 Financial Results and Recent Portfolio Execution
|
|
Jun 24
|
Kiniksa Pharmaceuticals Partners with NHL Hall-of-Famer Henrik Lundqvist to Raise Awareness of Recurrent Pericarditis
|
|
Jun 17
|
Kiniksa Pharmaceuticals Sponsors American Heart Association’s Addressing Recurrent Pericarditis Initiative
|
|
May 7
|
Kiniksa Pharmaceuticals to Present at Bank of America Securities 2024 Health Care Conference
|
|
Apr 26
|
Analyst Estimates: Here's What Brokers Think Of Kiniksa Pharmaceuticals, Ltd. (NASDAQ:KNSA) After Its First-Quarter Report
|
|
Apr 24
|
Kiniksa Pharmaceuticals First Quarter 2024 Earnings: Revenues Beat Expectations, EPS Lags
|
|
Apr 24
|
Kiniksa Pharmaceuticals, Ltd. (NASDAQ:KNSA) Q1 2024 Earnings Call Transcript
|
|
Apr 23
|
Kiniksa Pharmaceuticals Ltd (KNSA) Q1 2024 Earnings Overview: Surpasses Revenue Forecasts
|
|
Apr 23
|
Kiniksa Pharmaceuticals, Ltd. (KNSA) Reports Q1 Loss, Tops Revenue Estimates
|
|
Apr 23
|
Kiniksa Pharmaceuticals Reports First Quarter 2024 Financial Results and Recent Portfolio Execution
|
|
Apr 16
|
Kiniksa Pharmaceuticals to Report First Quarter 2024 Financial Results on April 23, 2024
|
|
Apr 2
|
Kiniksa Pharmaceuticals Announces Development Indication for Abiprubart
|
|
Mar 4
|
Arcturus (ARCT) Stock Surges 73% in 3 Months: Here's Why
|
|
Mar 1
|
Does Kiniksa Pharmaceuticals, Ltd. (KNSA) Have the Potential to Rally 32.45% as Wall Street Analysts Expect?
|